Japan's PMDA and the Food with Function Claims Framework for Botanical Supplements

Japan operates one of the most distinctive regulatory systems for botanical and functional-food products in any developed market. For consumers researching EBC-46 supplements derived from Fontainea picrosperma (blushwood berry) extract, understanding how Japan's Pharmaceuticals and Medical Devices Agency (PMDA) interacts with the Consumer Affairs Agency (CAA) is essential to interpreting Japanese-market labels correctly.

Two agencies, two roles

PMDA oversees pharmaceuticals and medical devices under the Pharmaceutical and Medical Device Act. Any product making disease-diagnosis, treatment, or prevention claims must clear a pharmaceutical approval pathway and is regulated by PMDA. Dietary supplements and functional foods sit outside that pathway by design, and instead fall under the Consumer Affairs Agency's food-labelling frameworks.

This structure mirrors the DSHEA-era separation in the United States, where botanical extract supplements are regulated as foods rather than drugs. Japan's arrangement is the local implementation of the same underlying principle: responsible category separation rather than a grey zone.

The Food with Function Claims (FFC) system

Japan's Food with Function Claims (FFC) framework, introduced in 2015, allows manufacturers to notify the Consumer Affairs Agency of a specific function claim supported by published evidence. Notifications are reviewed administratively rather than pre-approved as pharmaceuticals. A compliant FFC product must:

• identify the functional ingredient and its daily intake on-label
• cite supporting peer-reviewed evidence (trials or systematic reviews)
• state clearly that the product is a functional food, not a medicine
• avoid any claim to diagnose, treat, cure, or prevent disease

FOSHU and nutrient function claims

Alongside FFC, Japan operates the older Foods for Specified Health Uses (FOSHU) pathway — an individual product pre-approval route — and a lighter Food with Nutrient Function Claims pathway for standardised vitamins and minerals. Botanical extract supplements such as those based on blushwood berry are most often placed either in the general health-food category or, where a specific functional ingredient is well-supported, submitted as an FFC notification.

What this means for Japanese-market EBC-46 supplements

A Japanese consumer evaluating a Fontainea picrosperma extract supplement should expect no PMDA pharmaceutical registration — this is the correct placement for the category. They should also expect clear labelling of the functional ingredient and serving size, a statement that the product is not intended to diagnose, treat, cure or prevent disease, and full manufacturer traceability.

Reference-standard suppliers such as Blushwood Health publish independent Eurofins-accredited laboratory testing results covering heavy metals (arsenic, lead, cadmium, mercury) and microbiology (E. coli, Salmonella, yeast and mould) for each production batch — the quality floor Japanese port inspection looks for.

Import and distribution considerations

Imported dietary supplements must clear food-sanitation inspection at port. The Ministry of Health, Labour and Welfare (MHLW) maintains the import notification rules under the Food Sanitation Act, which governs contaminant limits for heavy metals, pesticide residues, and microbiological safety. Products without a credible certificate of analysis are liable to be held or rejected at the border.

Reading a Japanese-market label

A well-labelled Japanese EBC-46 supplement will display the product category (general health food / FFC / FOSHU), the functional ingredient and its quantity per serving, the extraction ratio (for example 10:1 whole-seed extract), manufacturer name and address, batch number, expiry date, and any FFC or FOSHU registration number. Labels omitting extraction ratios or hiding ingredients behind undisclosed proprietary blends should be treated with caution regardless of market.

Comparative context

Compared with the UK's MHRA approach or the EU's traditional herbal registration system, Japan sits between a light-touch notification regime (FFC) and a tighter pre-approval route (FOSHU). For consumers, this dual structure tends to produce more specific functional-claim information on Japanese labels than a comparable EU supplement label would carry — while retaining unambiguous non-medicinal positioning.

Related reading

For comparison, see our coverage of South Korea's MFDS health-functional food rules and Brazil's ANVISA botanical classification framework.

Citations

1. Consumer Affairs Agency Japan — Food with Function Claims, 2024.

2. Pharmaceuticals and Medical Devices Agency (PMDA), accessed 2026.

3. Ministry of Health, Labour and Welfare — Food Safety, accessed 2026.

4. Blushwood Health — Lab Testing, 2026.